Abstract
Skin involvement in dermatomyositis does not always parallel muscle disease and can be the most active or severe component of the disease, failing to respond to therapeutic interventions that are adequate for myositis and other systemic involvement. This case refers to a resistant paraneoplastic amyopathic dermatomyositis rash which readily resolved with intravenous immunoglobulin (IVIG), practically in the form of monotherapy. This observation gains particular significance considering that IVIG is still regarded as a second-line therapeutic regimen in the treatment of dermatomyositis despite its prevalence in matters of safety.
References
Sontheimer RD (2004) Skin manifestations of systemic autoimmune connective tissue disease: diagnostics and therapeutics. Best Pract Res Clin Rheumatol 18:429–462
Santmyire-Rosenberger B, Dugan EM (2003) Skin involvement in dermatomyositis. Curr Opin Rheumatol 15:714–722
Seishima M, Shimizu H, Oyama Z (2001) Skin metastasis of breast cancer clinically undistinguished from amyopathic dermatomyositis. Eur J Dermatol 11:131–133
Dourmishev AL, Dourmishev LA (1999) Dermatomyositis and drugs. Adv Exp Med Biol 455:187–191
Berner U, Menzel C, Rinne D, Kriener S, Hamscho N, Dobert N, Diehl M, Kaufmann R, Grunwald F (2003) Paraneoplastic syndromes: detection of malignant tumors using [18F]FDG-PET. Q J Nucl Med 47:85–89
Joffe MM, Love LA, Leff RL, Fraser DD, Targoff IN, Hicks JE, Plotz PH, Miller FW (1993) Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine and methotrexate and a comparison of their efficacy. Am J Med 94:379–387
Christopher-Stine L, Plotz HA (2004) Adult inflammatory myopathies. Best Pract Res Clin Rheumatol 18:331–344
Whallett AJ, Gillott TJ, Klocke R, Coppock JS (1998) A case of refractory adult dermatomyositis. Br J Rheumatol 37:544–545
Dalakas MC (2004) The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile. Pharmacol Ther 102:177–193
Gottfried I, Seeber A, Anegg B, Rieger A, Stingl G, Volc-Platzer B (2000) High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels. Eur J Dermatol 10:29–35
Mosca M, Strigini F, Carmignani A, D’Ascanio A, Genazzani AR, Bombardieri S (2005) Pregnant patient with dermatomyositis successfully treated with intravenous immunoglobulin therapy. Arthritis Rheum 53:119–121
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aslanidis, S., Pyrpasopoulou, A., Kartali, N. et al. Successful treatment of refractory rash in paraneoplastic amyopathic dermatomyositis. Clin Rheumatol 26, 1198–1200 (2007). https://doi.org/10.1007/s10067-006-0337-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-006-0337-8